A doctor treating obesity is optimizing for long-term metabolic health
GLP-1 receptor agonists, such as liraglutide (tested in multiple trials, including two focused on children under 12) and semaglutide (in one trial for individuals aged 12-18), have been shown to reduce BMI, body weight, and waist circumference significantly
Avoid or limit very high-fat meals (fried foods, heavy cream sauces), very spicy foods, high-sugar items, and large portions
After that, at 24 min, 100%/0% was kept until 27 min
It is studied and sold strictly as a research compound or off-label growth-hormone-axis agent explored for muscle growth and recovery, not as an approved therapeutic or an over-the-counter supplement
Oral administration increased plasma GLP-1 levels compared with water during an intraperitoneal glucose tolerance test, and ileal administration reduced plasma DPP4 activity and increased the ratio of active GLP-1 to total GLP-1 (Reference Ishikawa, Hira and Inoue69) in rats